After the screening of 860 healthy Finnish volunteers for the CES1 c.428G>A ( p.Gly143Glu , rs121912777 ) polymorphism , a pharmacokinetic study with 75 mg oseltamivir was carried out in c.428G>A carriers and noncarriers .